Bunkerhill AVC vs Reveal LINQ Insertable Cardiac Monitor

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 60/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

Bunkerhill AVC

by Bunkerhill Health

Reveal LINQ Insertable Cardiac Monitor

by Medtronic

AI Verdict

Tool A (Bunkerhill AVC) is a software platform that leverages AI to analyze existing CT scans for the early detection and quantification of structural heart conditions like aortic valve calcification, integrating with EHRs for clinical decision support. In contrast, Tool B (Reveal LINQ ICM) is an implantable cardiac monitor that uses AI to provide long-term, continuous ECG monitoring, focusing on reducing false alerts for rhythm disorders such as atrial fibrillation and syncope. While both utilize AI in cardiology, they serve distinct diagnostic purposes and employ fundamentally different technologies and data sources.

Choose Bunkerhill AVC if…

Choose Bunkerhill AVC if your health system aims to opportunistically screen and quantify cardiovascular calcifications (aortic, coronary, mitral) and bone density from existing chest CT scans. This tool integrates directly with EHRs to automate the detection and quantification process, leveraging generative AI to enhance clinical reasoning and workflow efficiency for incidental findings. It's ideal for improving early detection and risk stratification across a patient population using already acquired imaging data.

View Bunkerhill AVC →

Choose Reveal LINQ Insertable Cardiac Monitor if…

Choose the Reveal LINQ Insertable Cardiac Monitor if you need long-term, continuous, and highly accurate monitoring of cardiac rhythms for patients experiencing infrequent or unexplained symptoms like syncope or palpitations. This implantable device utilizes advanced AI algorithms to significantly reduce false alerts, ensuring a higher diagnostic yield for conditions such as atrial fibrillation. It is best suited for patients requiring extended monitoring beyond the capabilities of external devices.

View Reveal LINQ Insertable Cardiac Monitor →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	Bunkerhill AVC	Reveal LINQ Insertable Cardiac Monitor
Pricing	Unknown	Contact vendor
Deployment	Unknown	Implantable device with data transmitted to a cloud-based platform (CareLink™ network) via patient smartphone app or home communicator.
BAA Available	Yes AI-estimated	Yes AI-estimated
FDA Status	Cleared AI-estimated	Yes AI-estimated
HIPAA	Yes AI-estimated	Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Bunkerhill AVC

Tool A, Bunkerhill AVC, integrates directly with Electronic Health Records (EHRs) and offers natural language processing for patient record interaction, suggesting a seamless workflow for clinicians within their existing systems. This direct integration and AI-powered interaction likely provide a more intuitive and less disruptive experience compared to managing data from a separate implantable device system like Tool B.

Clinical Value

Tie

Both tools offer significant and distinct clinical value, each being FDA-cleared for their specific applications. Tool A provides opportunistic detection and quantification of various calcifications and bone density from existing CTs, aiding in risk assessment. Tool B, an implantable device, offers long-term, accurate heart monitoring with AI to reduce false alerts, enhancing diagnostic yield for conditions like atrial fibrillation and syncope.

Pricing & Value

Tie

Neither Tool A nor Tool B provides publicly disclosed pricing information, both requiring direct contact with their respective sales teams. Without transparent pricing details, it is impossible to conduct a head-to-head comparison of their value propositions.

Enterprise Readiness

Bunkerhill AVC

Tool A demonstrates strong enterprise readiness through its direct integration with full EHRs and clinical archives, along with customizable AI agents designed for diverse workflows within health systems. While Tool B is from a large, established company, its deployment model involving an implantable device and a separate cloud platform may introduce different integration considerations compared to Tool A's deep EHR integration.

Innovation

Bunkerhill AVC

Tool A stands out with its use of 'Generative AI for clinical reasoning and action' and 'Natural language processing for patient record interaction (Carebricks Chat),' representing cutting-edge applications of AI in healthcare. Tool B's innovation primarily focuses on refining the accuracy of an existing medical device category through deep learning algorithms to reduce false alerts.

Support & Docs

Reveal LINQ Insertable Cardiac Monitor

As a product from Medtronic, a globally recognized leader in medical technology, Tool B is expected to have comprehensive support, training, and documentation resources available to both clinicians and patients. The provided information for Tool A does not include any specific details regarding its support or documentation offerings.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	Bunkerhill AVC	Reveal LINQ Insertable Cardiac Monitor
Name	Bunkerhill AVC	Reveal LINQ Insertable Cardiac Monitor
Company	BunkerHill Health	Medtronic
Description	Bunkerhill Health provides a generative AI platform, Carebricks, for clinical reasoning and action, integrating with EHRs to automate workflows and improve patient outcomes. Its FDA-cleared algorithm, Bunkerhill AVC, specifically aids in the early detection and quantification of aortic valve calcification from chest CTs.	The Medtronic LINQ II™ Insertable Cardiac Monitor (ICM) with AccuRhythm™ AI algorithms provides long-term, accurate heart monitoring by using deep learning AI to reduce false alerts and enhance diagnostic yield for conditions like atrial fibrillation and syncope.
Categories	Cardiology AI, Clinical Decision Support & Reference	Cardiology AI, Wearables & Remote Monitoring (RPM)
Specialties	Cardiology, Radiology	Cardiology, Pediatrics
Key Features	Generative AI for clinical reasoning and action, Automated detection and quantification of aortic valve calcification (Bunkerhill AVC), Automated detection and quantification of coronary artery calcification (iCAC, Contrast CAC), Automated detection and quantification of mitral annular calcification (Bunkerhill MAC), Opportunistic bone density assessment (Bunkerhill BMD), Integration with Electronic Health Records (EHRs) and clinical archives, Customizable AI agents for diverse workflows, Natural language processing for patient record interaction (Carebricks Chat)	AccuRhythmu2122 AI algorithms for reduced false alerts (AF and Pause), 4.5-year battery longevity (nominal settings), Continuous, long-term subcutaneous ECG monitoring, Remote programming capabilities, Enhanced ECG experience for clinical adjudication, MyCareLink Heartu2122 mobile app for patient data transmission, MyCareLink Relayu2122 home communicator for data transmission, MRI compatible (at u2264 3T with no post-insertion waiting)

Videos

Demos, reviews, and walkthroughs featuring Bunkerhill AVC and Reveal LINQ Insertable Cardiac Monitor.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

What is the primary difference in how these tools utilize AI?

Bunkerhill AVC uses generative AI for clinical reasoning and action, specifically for automated detection and quantification of various calcifications (aortic valve, coronary artery, mitral annular) and opportunistic bone density assessment from chest CTs. In contrast, the Reveal LINQ Insertable Cardiac Monitor utilizes AccuRhythmu2122 AI algorithms to reduce false alerts and enhance diagnostic yield for conditions like atrial fibrillation and syncope from continuous ECG monitoring.

How do these tools integrate into existing clinical workflows?

Bunkerhill AVC is a software platform that integrates with full Electronic Health Records (EHRs) and clinical archives within health systems, allowing for customizable AI agents and natural language processing for patient record interaction. The Reveal LINQ Insertable Cardiac Monitor is an implantable device that transmits data to a cloud-based platform (CareLinku2122 network) via a patient smartphone app or home communicator for remote monitoring.

What specific patient conditions or diagnostic needs do these tools address?

Bunkerhill AVC focuses on the early detection and quantification of aortic valve calcification, coronary artery calcification, mitral annular calcification, and opportunistic bone density assessment from chest CTs. The Reveal LINQ Insertable Cardiac Monitor is designed for long-term, accurate heart monitoring to diagnose conditions such as atrial fibrillation, syncope, and other cardiac arrhythmias.

Which medical specialties are primarily targeted by each tool?

Bunkerhill AVC is primarily targeted towards Cardiology and Radiology specialties, given its focus on analyzing CT scans for calcification and bone density. The Reveal LINQ Insertable Cardiac Monitor is primarily used in Cardiology and Pediatrics for long-term cardiac rhythm monitoring.

How do these tools assist in clinical decision-making?

Bunkerhill AVC assists by providing automated detection and quantification of calcifications from CTs, offering generative AI for clinical reasoning and action to improve patient outcomes. The Reveal LINQ Insertable Cardiac Monitor aids by providing continuous, long-term ECG monitoring with AI algorithms that reduce false alerts, thereby enhancing diagnostic yield for cardiac arrhythmias.